All patients from HF+ group and almost all HF- patients received at discharge upon index hospitalization for STEMI and continued for at least 12 months beta blocker, angiotensin-converting enzyme inhibitor, and high-intensity statin therapy. This evidence concerns the gene ACE and hydrops fetalis.